title: Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy.
abstract: We studied the dynamics of serum leptin level and some anthropometric values in patients with schizophrenia treated with risperidone, olanzapine, and clozapine showed gender-dependent specific correlations between the studied parameters.
authors.affiliation: Department of Psychiatric Endocrinology, Moscow Institute of Psychiatry, Federal Agency for Health Care and Social Development, Russia. gorobetsln@mail.ru
authors.forename: L N
authors.initials: LN
authors.lastname: Gorobets
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D003024:Clozapine / Q000009:adverse effects; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood*; D008297:Male; D009765:Obesity / Q000097:blood / Q000209:etiology*; D000077152:Olanzapine; D018967:Risperidone / Q000009:adverse effects; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D012737:Sex Factors; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D020738:Leptin; D001569:Benzodiazepines; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine